I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Mark Delaney Biography and Net Worth

SVP of Quest Diagnostics

Mark Delaney is Senior Vice President and Chief Commercial Officer, responsible for all sales operations.

Prior to joining Quest Diagnostics in March 2022, Mark had been Vice President for Sales and Marketing at Hillrom for more than four years, and became Vice President and General Manager at Baxter after it acquired Hillrom.

Previously, Mark had held senior sales and marketing leadership roles at GE Healthcare. Most recently he was Senior Vice President and Zone Manager, where he had regional responsibility for sales of imaging, patient monitoring, IT, and services.

Mark holds a bachelor’s degree in economics from St. Lawrence University and an Executive MBA from Suffolk University.

What is Mark E. Delaney's net worth?: The estimated net worth of Mark E. Delaney is at least $821,058.21 as of July 24th, 2024. Mr. Delaney owns 5,019 shares of Quest Diagnostics stock worth more than $821,058 as of November 23rd. This net worth evaluation does not reflect any other investments that Mr. Delaney may own. Learn More about Mark E. Delaney's net worth.
How do I contact Mark E. Delaney?: The corporate mailing address for Mr. Delaney and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Mark E. Delaney's contact information.
Has Mark E. Delaney been buying or selling shares of Quest Diagnostics?: Mark E. Delaney has not been actively trading shares of Quest Diagnostics during the last ninety days. Most recently, Mark E. Delaney sold 420 shares of the business's stock in a transaction on Wednesday, July 24th. The shares were sold at an average price of $143.08, for a transaction totalling $60,093.60. Following the completion of the sale, the senior vice president now directly owns 5,019 shares of the company's stock, valued at $718,118.52. Learn More on Mark E. Delaney's trading history.
Who are Quest Diagnostics' active insiders?: Quest Diagnostics' insider roster includes Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.
Are insiders buying or selling shares of Quest Diagnostics?: In the last twelve months, insiders at the medical research company sold shares 10 times. They sold a total of 39,850 shares worth more than $5,692,423.40. The most recent insider tranaction occured on November, 6th when CAO Michael J Deppe sold 18,755 shares worth more than $2,889,207.75. Insiders at Quest Diagnostics own 0.8% of the company. Learn More about insider trades at Quest Diagnostics.
Information on this page was last updated on 11/6/2024.

Mark E. Delaney Insider Trading History at Quest Diagnostics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/24/2024	Sell	420	$143.08	$60,093.60	5,019

Mark E. Delaney Buying and Selling Activity at Quest Diagnostics

Quest Diagnostics Company Overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Today's Range

Now: $163.59

$163.40

$165.10

50 Day Range

MA: $154.66

$146.83

$164.19

2 Week Range

Now: $163.59

$123.04

$165.10

Volume

589,234 shs

Average Volume

919,900 shs

Market Capitalization

$18.26 billion

P/E Ratio

21.99

Dividend Yield

1.86%

Beta

0.89

I was wrong. Dead wrong.

From Porter & Company | Ad